What do current multiple myeloma clinical trials have in common?
Treatment options for patients with advanced multiple myeloma
Overview of a Phase II clinical trial of isatuximab
TOURMALINE-MM1 study produces optimistic results for MM
The question of drug combinations for consolidation and maintenance for multiple myeloma